DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Wagner U, Marth C, Largillier R. et al.
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs. paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
Br J Cancer 2012;
107: 588-591
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.